Shimura Tetsuro, Yamamoto Masanori, Matsuo Hitoshi
Department of Cardiology, Gifu Heart Center, 4-14-4 Yabuta-minami, Gifu-city, Gifu 500-8384, Japan.
Department of Cardiology, Toyohashi Heart Center, 21-1 Gobutori, Oyama-cho, Toyohashi, Aichi 441-8530, Japan.
Eur Heart J Case Rep. 2024 Nov 26;8(12):ytae622. doi: 10.1093/ehjcr/ytae622. eCollection 2024 Dec.
Computed tomography (CT) assessment is the standard for predicting coronary obstruction (CO) caused by sinus sequestration (SS) during transcatheter aortic valve (TAV) implantation in degenerated TAV (TAV-in-TAV) procedure, but it may not always be accurate. This report describes a prediction method for CO by using balloon aortic valvuloplasty (BAV) during TAV-in-TAV.
An 87-year-old woman with a history of balloon-expandable transcatheter heart valve (BE-THV) implantation 7 years prior was admitted with worsening dyspnoea. Echocardiography revealed severe THV deterioration, and CT confirmed calcium proliferation in the THV. Our heart team decided to perform a TAV-in-TAV procedure using a 23-mm BE-THV. Preoperative CT imaging indicated an intermediate risk of CO. To evaluate CO risk more precisely, the top of a 20-mm balloon was positioned near the top of a BE-THV stent and inflated, followed by simultaneous aortic root injection (SARI). During SARI, contrast flowed into both coronary arteries, predicting a low risk of CO. Based on these findings, TAV-in-TAV was performed without coronary protection. The procedure was completed successfully without CO. After the procedure, the patient's symptoms improved, and echocardiography showed normal valve function. She was discharged without complications and remains under outpatient follow-up care.
The diagnostic method for predicting CO using BAV with SARI could serve as a valuable adjunctive diagnostic tool in patients with an intermediate or high risk of SS anatomy after TAV-in-TAV. In such cases, this method may provide additional insights concerning precise CO risk and the indication of leaflet modification technique during TAV-in-TAV.
在经导管主动脉瓣植入术(TAV)治疗退化性主动脉瓣(TAV-in-TAV)过程中,计算机断层扫描(CT)评估是预测由窦房结隔离(SS)引起的冠状动脉阻塞(CO)的标准方法,但它并不总是准确的。本报告描述了一种在TAV-in-TAV过程中使用球囊主动脉瓣成形术(BAV)预测CO的方法。
一名87岁女性,7年前有球囊扩张型经导管心脏瓣膜(BE-THV)植入史,因呼吸困难加重入院。超声心动图显示THV严重退化,CT证实THV中有钙增生。我们的心脏团队决定使用23毫米BE-THV进行TAV-in-TAV手术。术前CT成像显示CO风险为中度。为了更精确地评估CO风险,将一个20毫米球囊的顶部放置在BE-THV支架顶部附近并充气,随后进行同步主动脉根部注射(SARI)。在SARI期间,造影剂流入双侧冠状动脉,预测CO风险较低。基于这些发现,在没有冠状动脉保护的情况下进行了TAV-in-TAV手术。手术成功完成,未发生CO。术后,患者症状改善,超声心动图显示瓣膜功能正常。她顺利出院,无并发症,仍在门诊接受随访。
使用BAV联合SARI预测CO的诊断方法可作为TAV-in-TAV术后SS解剖结构中度或高度风险患者的有价值的辅助诊断工具。在这种情况下,该方法可能为TAV-in-TAV期间精确的CO风险和瓣叶改良技术的指征提供更多见解。